Vertical Integration, Open Enrollment, and Aligning Healthcare with the People We Serve

As organizations prepare for open enrollment, one question deserves careful consideration:

Are our healthcare benefits aligned with the best interests of the people we serve?

For employers, public agencies, labor organizations, and healthcare purchasers, open enrollment is more than an annual enrollment exercise. It is an opportunity to evaluate whether healthcare dollars are being used efficiently, transparently, and in a manner that supports both organizational sustainability and patient care.

At the same time, vertical integration continues to reshape healthcare. Health plans increasingly own or control multiple parts of the care delivery system, including physician groups, pharmacies, clinics, infusion providers, and other healthcare services. While this can create operational efficiencies, it can also make it more difficult to understand how decisions are made, where dollars flow, and whether incentives remain aligned with patients and plan sponsors.

This is especially important because employer-sponsored healthcare remains the primary source of coverage for millions of Americans. Employers hire people based on their qualifications, skills, experience, and ability to contribute, not their health status. Yet the healthcare financing system often operates differently.

A challenge known as “adverse selection” can create incentives that unintentionally favor lower-risk populations while making it more difficult to support those with greater healthcare needs. Over time, this can undermine one of the fundamental principles of insurance: spreading risk across broad populations. As a result, plan sponsors should look beyond premiums alone and ask whether their benefit strategy promotes long-term sustainability, transparency, accountability, and equitable access to care for the people they serve.

To navigate the complexity of this environment, many businesses depend upon healthcare consultants. Employer plan sponsors have fiduciary obligations to manage benefits appropriately for their employee beneficiaries. Consultants should support those obligations through objective guidance and aligned incentives. In the absence of such alignment with the employers’ fiduciary obligations, employers should carefully evaluate whether a consultant’s recommendations are serving the interests of their workforce or those of the vendors being recommended.

From my experience as a pharmacist, healthcare executive, and educator, meaningful stewardship begins with integrity and transparency. Employers deserve visibility into the total cost of care, independent oversight, aligned incentives, and a connected approach to managing medical and pharmacy benefits with an entity they can trust. These principles become even more important as healthcare systems grow larger and more complex.

For more than 22 years, Ventegra has advanced the Medical Benefit Management (MBM) model based on a simple belief: healthcare works best when decisions are guided by the needs of patients and the communities we serve, not by the interests of intermediaries. Through integrity, transparency, accountability, and the elimination of conflicts of interest, we believe organizations can create more sustainable healthcare solutions that deliver value for both patients and plan sponsors.

As you evaluate your healthcare benefit partnerships this open enrollment season, consider this fundamental question:

Are your benefits truly aligned with the people they are intended to serve?

It’s a question worth asking—not simply about cost and coverage, but about transparency, accountability, access, and the experience of the people who depend on those benefits every day.

I believe that this question has never been more important.

If your organization is evaluating its healthcare benefit strategy and looking for more effective ways to align incentives, support your workforce, and promote long-term plan sustainability, I welcome the opportunity to connect and continue the conversation.

Robert T. Taketomo, PharmD, MBA
President & CEO of Ventegra, Inc.
President & CEO, and Chairman of the Board of the Ventegra Foundation